Ndihokubwayo J B, Baribwira C, Ndayiragije A, Poste B
Département de Biologie Médicale, Centre Hospitalo-Universitaire de Bujumbura, Burundi.
Med Trop (Mars). 1996;56(1):37-40.
Bacillary dysentery which occurs endemoepidemically in Burundi is currently on the rise and requires close epidemiologic and therapeutic monitoring. Sensitivity tests using 13 antibiotics were performed on 299 strains of shigella isolated at the Biology Laboratory of the Bujumbura University Hospital Center. The technique used to test antibiotic sensitivity was the disc diffusion method described by Chabert et al. Of the 299 strains studied, 250 (83.6%) were species of Shigella dysenteriae type 1. All isolated Shigella bacillus were resistant to ampicillin, sulfamethoxazole-trimethoprim, tetracyclin, and chloramphenicol. Ninety-seven percent of Shigella dysenteriae type 1 serotype presented resistance to nalidixic acid while the 2 serotypes (0.8%) showed partial resistance to pefloxacine and norfloxacine. No resistance was observed to cefotaxim, colistin, and neomycin. Multiresistance of Shigella bacillus isolated in Bujumbura supports involvement of a plasmid mechanisms and suggests that the effectiveness of antibiotherapy against shigellosis is limited. This study suggests that a preventive campaign for bacillary dysentery should be undertaken in Burundi.
在布隆迪以地方性流行形式出现的细菌性痢疾目前呈上升趋势,需要进行密切的流行病学和治疗监测。在布琼布拉大学医院中心生物实验室对分离出的299株志贺氏菌进行了13种抗生素的敏感性测试。用于测试抗生素敏感性的技术是Chabert等人描述的纸片扩散法。在所研究的299株菌株中,250株(83.6%)是痢疾志贺氏菌1型。所有分离出的志贺氏杆菌对氨苄青霉素、磺胺甲恶唑-甲氧苄啶、四环素和氯霉素均耐药。97%的痢疾志贺氏菌1型血清型对萘啶酸耐药,而2个血清型(0.8%)对培氟沙星和诺氟沙星呈部分耐药。未观察到对头孢噻肟、黏菌素和新霉素的耐药情况。在布琼布拉分离出的志贺氏杆菌多重耐药表明存在质粒机制参与,这提示针对志贺氏菌病的抗微生物治疗效果有限。这项研究表明布隆迪应开展细菌性痢疾预防运动。